MedPath

EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION

🇪🇸Spain
Ownership
-
Established
1974-01-01
Employees
-
Market Cap
-
Website
https://www.ebmt.org/Contents/Pages/Default.aspx

Clinical Trials

31

Active:2
Completed:16

Trial Phases

3 Phases

Phase 1:1
Phase 2:6
Phase 3:9

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Phase 3
9 (56.3%)
Phase 2
6 (37.5%)
Phase 1
1 (6.3%)

Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML

Completed
Conditions
CMML
MDS
First Posted Date
2024-02-20
Last Posted Date
2024-02-20
Lead Sponsor
European Society for Blood and Marrow Transplantation
Target Recruit Count
222
Registration Number
NCT06267898
Locations
🇧🇪

Antwerp University Hospital (UZA), Antwerp, Belgium

🇧🇪

University Hospital Gasthuisberg, Leuven, Belgium

🇧🇪

University of Liege, Liege, Belgium

and more 3 locations

Stem Cell Translpantation in Multiple Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma
First Posted Date
2021-10-19
Last Posted Date
2023-09-11
Lead Sponsor
European Society for Blood and Marrow Transplantation
Target Recruit Count
357
Registration Number
NCT05082675
Locations
🇦🇹

Medizinische Universität Wien, Wien, Austria

🇩🇰

Rigshospitalet, Copenhagen, Denmark

🇩🇰

Herlev Hospital, Herlev, Denmark

and more 17 locations

A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCT

Completed
Conditions
Pneumocystis Pneumonia
First Posted Date
2021-10-14
Last Posted Date
2023-05-15
Lead Sponsor
European Society for Blood and Marrow Transplantation
Target Recruit Count
168
Registration Number
NCT05077150
Locations
🇧🇪

University Hospital Gasthuisberg, Leuven, Belgium

🇫🇷

University of Amiens: CHU Amiens, Amiens, France

🇫🇷

Hôpital Henri Mondor, Creteil, France

and more 6 locations

Autologous Stem Cell Transplantation: International Lupus Trial

Phase 2
Withdrawn
Conditions
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Interventions
Biological: Autologous Hematopoietic Stem Cell Transplantation
First Posted Date
2021-10-01
Last Posted Date
2023-09-13
Lead Sponsor
European Society for Blood and Marrow Transplantation
Registration Number
NCT05063513
Locations
🇫🇷

Dept. of Internal Medicine, Hôpital Saint-Louis, Paris Cedex 10, France

ECP Combination Study

Completed
Conditions
Steroid Refractory GVHD
Interventions
Device: Extracorporeal photopheresis
First Posted Date
2021-09-22
Last Posted Date
2024-03-28
Lead Sponsor
European Society for Blood and Marrow Transplantation
Target Recruit Count
319
Registration Number
NCT05052385
Locations
🇧🇪

Antwerp University, Antwerp, Belgium

🇧🇪

University of Liège, Liège, Belgium

🇩🇰

Rigshospitalet, Copenhagen, Denmark

and more 35 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.